QNTM
Quantum Biopharma Ltd. Class B Subordinate Voting Shares
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
QNTM Stock Analysis: Buy, Sell, or Hold?
$1.94
-0.08 (-3.96%)
▼
5d:
-12.22%
30d:
-32.87%
90d:
-39.94%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 13, 2026
TODAY
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
41/100
Position
OVERSOLD
30-Day Fair Range
$2.12 – $2.85
Position: OVERSOLD
Wall Street Target
$12.29
+533.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.91 / $2.50
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: QNTM is down 12.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When QNTM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: QNTM is currently trading at $1.94, which is considered oversold relative to its 30-day fair value range of $2.12 to $2.85.
Technical Outlook: Technically, QNTM is in a downtrend. The price is currently testing key support at $1.91. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: QNTM scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.29 (+533.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, QNTM is in a downtrend. The price is currently testing key support at $1.91. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: QNTM scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.29 (+533.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.12 -
$2.85
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Trading Range & Key Levels
30-Day Trading Range
$2.12 -
$2.85
Current vs Trading Range
OVERSOLD
Support Level
$1.91
Resistance Level
$2.50
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.0%)
- BULLISH: Trading 533.5% below Wall St target ($12.29)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Wall Street Target
$12.29
(+533.5%)
Share QNTM Analysis
Share this live QNTM analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (QNTM)
Bearish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
Quantum BioPharma (QNTM) held its annual general and special meeting of shareholders, reporting the election of all director nominees and the reappointment of MNP LLP as auditor. The company also announced the closing of a C$80.86 private placement, increasing insider voting control to 68.22%.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 9:30 AM ET
Data refreshes hourly during market hours. Next update: 10:30 AM
Data refreshes hourly during market hours. Next update: 10:30 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QNTM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 53 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 41 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 51 HOLD |
|
SNDX
Syndax Pharmaceuticals I… |
STRONG BUY
12 analysts |
$35 | 60 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive QNTM Research Pages